Masnavi Capital
Overview
Masnavi Capital is a venture capital firm based in Kyiv, Ukraine, focusing on seed-stage investments in sectors such as biotechnology, financial services, food and beverage, health care, information technology, medical, and software. The firm has a geographical focus on North America and Europe, with investments in the United States, Germany, the United Kingdom, Singapore, and Ukraine. Masnavi Capital's investment stages include seed, early-stage venture, late-stage venture, and convertible notes. The firm's portfolio companies include Orbillion Bio, 100Plus, Boundary Layer Technologies, atai Life Sciences, and Credolab. Notable exits include atai Life Sciences and 100Plus. The firm is led by founder A. K. and operates with a team of 1-10 employees.
Investment Focus
- Impact-oriented startups
- Early-stage companies
- Companies in biotechnology, financial services, food and beverage, health care, information technology, medical, and software sectors
Portfolio Companies
Reach Masnavi Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Masnavi Capital
What sectors does Masnavi Capital invest in?
Masnavi Capital invests in Financial Services, Software, Credit, Consumer, FinTech and Health Care, and is based in Ukraine. Masnavi Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Masnavi Capital invest at?
Masnavi Capital backs companies at Seed, writing cheques of 1M - 2M.
Which regions does Masnavi Capital invest in?
Masnavi Capital invests across United States, United Kingdom, Germany, Singapore and Ukraine.
What companies has Masnavi Capital invested in?
Masnavi Capital's portfolio includes ATAI Life Sciences, 100Plus, Orbillion Bio, Boundary Layer Technologies and Credolab.
Last updated · Source: ConnectSafely investor database
